title: Recombinant human gamma interferon enhances in vitro activation of lymphocytes isolated from patients with acquired immunodeficiency syndrome.
abstract: Decreased responses to antigens and lectins are a characteristic feature of peripheral blood lymphocytes isolated from patients with the acquired immunodeficiency syndrome (AIDS). The in vitro addition of recombinant gamma interferon (IFN-gamma) to cultures of peripheral blood lymphocytes obtained from patients with AIDS resulted in an augmented proliferative response [( 3H]thymidine uptake) to phytohemagglutinin (PHA) and an enrichment in CD4+ and CD8+ T lymphocytes. In AIDS cultures stimulated with PHA, IFN-gamma increased the release of T-cell growth factors and enhanced the expression of interleukin-2 receptors on activated lymphocytes. Responsiveness to PHA was augmented, albeit to a lesser extent, by IFN-gamma in cultures derived from normal donors. Proliferation to microbial antigens including herpes simplex virus, cytomegalo virus, and Candida albicans was increased by IFN-gamma in cultures established from a group of AIDS patients with Kaposi's sarcoma who had no history of opportunistic infection.
authors.affiliation: Laboratory of Infectious Diseases, Dana-Farber Cancer Institute, Boston, Massachusetts 02115.
authors.forename: W
authors.initials: W
authors.lastname: Heagy
authors.forename: T B
authors.initials: TB
authors.lastname: Strom
authors.forename: V E
authors.initials: VE
authors.lastname: Kelley
authors.forename: J
authors.initials: J
authors.lastname: Collela
authors.forename: C
authors.initials: C
authors.lastname: Crumpacker
authors.forename: J M
authors.initials: JM
authors.lastname: Williams
authors.forename: H M
authors.initials: HM
authors.lastname: Shapiro
authors.forename: L
authors.initials: L
authors.lastname: Laubenstein
authors.forename: R
authors.initials: R
authors.lastname: Finberg
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology*; D000942:Antigens, Bacterial / Q000276:immunology; D000945:Antigens, Differentiation, T-Lymphocyte; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D016827:CD8 Antigens; D002478:Cells, Cultured; D006801:Humans; D066298:In Vitro Techniques; D007370:Interferon Type I / Q000494:pharmacology; D007371:Interferon-gamma / Q000494:pharmacology*; D037102:Lectins; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D008222:Lymphokines / Q000378:metabolism; D015375:Receptors, Interleukin-2 / Q000378:metabolism; D011994:Recombinant Proteins; D012514:Sarcoma, Kaposi / Q000276:immunology; D013223:Statistics as Topic
chemical_list: D000942:Antigens, Bacterial; D000945:Antigens, Differentiation, T-Lymphocyte; D016827:CD8 Antigens; D007370:Interferon Type I; D037102:Lectins; D008222:Lymphokines; D015375:Receptors, Interleukin-2; D011994:Recombinant Proteins; D007371:Interferon-gamma